Amikacin induced Stevens Johnson syndrome and toxic epidermal necrolysis overlap: a rare case report

C. Sai Chandu; T. Chandana; R. Sakshi; Karra Geetha; T. Ramarao

doi:10.18203/2394-6040.ijcmph20241206

Authors

C. Sai Chandu Department of Pharm D., CMR College of Pharmacy, Kandlakoya, Medchal, Telangana, India
T. Chandana Department of Pharm D., CMR College of Pharmacy, Kandlakoya, Medchal, Telangana, India
R. Sakshi Department of Pharm D., CMR College of Pharmacy, Kandlakoya, Medchal, Telangana, India
Karra Geetha Department of Pharmaceutics, CMR College of Pharmacy, Kandlakoya, Medchal, Telangana, India
T. Ramarao Department of Pharmaceutical Chemistry, CMR College of Pharmacy, Kandlakoya, Medchal, Telangana, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20241206

Keywords:

Stevens-Johnson syndrome, Toxic epidermal necrolysis, Antibiotics

Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are the most severe adverse drug reactions. They are characterized by necrosis and epidermal release in vesicobulosa skin, mucous orifice, and eyes, with more severe general symptoms. SJS/TEN-overlap syndrome is the term used to characterize situations where 10–30% of the body skin area is detached. TEN or SJS is one of the deadliest dermatological catastrophes. Despite being a rare condition, it frequently has a high death rate. Different types of purpuric macules or rounded patches with mucosal lesions are characteristic features of these type 3 hypersensitivity reactions. We are presenting a case of 50-year-old female patient brought to hospital on account of multiple black to red coloured raised lesions over body in the last 8 days. Patient was asymptomatic in the last 8 days after that patient noted red coloured lesions first over face followed by lower back, upper limb, lower limb followed by itching and Jiburning sensation all over the body. The patient had symptoms such as redness of eyes in the last 3-4 days, burning sensation and ulcers in mouth in the last 3-4 days. These symptoms developed day after she received amikacin. She was diagnosed with SJS-TEN overlap. This case highlights the precipitant of antibiotics for SJS. She was recovered completely after stopping the causative drug and treatment with Immunoglobulin with other symptomatic measures. The causative drug was found to be Amikacin and medicine taken for comorbid conditions like epilepsy, hypothyroidism and hypertension. Rarely, amikacin has been linked to a range of drug hypersensitivity reactions, including toxic epidermal necrolysis, Stevens-Johnson syndrome, and overlap between the two conditions.

Metrics

Metrics Loading ...

References

Ueta M. Pathogenesis of Stevens-Johnson Syndrome/toxic epidermal necrolysis with severe ocular complications. Frontiers Med. 2021;8.

Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on Stevens-Johnson Syndrome and toxic epidermal necrolysis. Clin Rev Aller Immunol. 2017;54(1):147-76.

Zimmerman D, Dang NH. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Oncologic Critical Care. 2019: 267-280.

Sánchez-Borges M, Thong B, Blanca M, Ensina LF, González-Díaz S, Greenberger PA, et al. Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO Special Committee on Drug Allergy. World Allergy Organization J. 2013;6:18.

Sharma V, Sethuraman G, Minz A. Stevens Johnson Syndrome, toxic epidermal necrolysis and SJS-TEN OVERLAP: A retrospective study of causative drugs and clinical outcome. Indian J Dermatol Venereol Leprol. 2008;74(3):238.

Wang L, Varghese S, Bassir F, Lo Y-C, Ortega CA, Shah S, et al. Stevens-Johnson Syndrome and toxic epidermal necrolysis: A systematic review of pubmed/Medline case reports from 1980 to 2020. Frontiers Med. 2022;9.

Shi T, Chen H, Huang L, Fan H, Yang D, Zhang D, et al. Fatal pediatric Stevens-Johnson Syndrome/toxic epidermal necrolysis. Medicine. 2020;99(12).

Shanbhag SS, Chodosh J, Fathy C, Goverman J, Mitchell C, Saeed HN. Multidisciplinary care in Stevens-Johnson syndrome. Therap Adv Chronic Dis. 2020;11:204062231989446.

Suresh Kumar P, Thomas B, Kumar K, Kumar S. Stevens-Johnson syndrome-toxic epidermal necrolysis (SJS-TEN) overlap associated with carbamazepine use. Indian J Psychiat. 2005;47(2):121.

Gupta L, Martin A, Agarwal N, D’Souza P, Das S, Kumar R, et al. Guidelines for the management of Stevens-Johnson Syndrome/toxic epidermal necrolysis: An indian perspective. Indian J Dermatol Venereol Leprol. 2016;82(6):603.

Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson Syndrome. Orphanet J Rare Dis. 2010;5(1).

Wong A, Malvestiti AA, Hafner M de. Stevens-Johnson Syndrome and toxic epidermal necrolysis: A Review. Revista da Associação Médica Brasileira. 2016;62(5):468-73.

French LE. Toxic epidermal necrolysis and Stevens Johnson Syndrome: Our current understanding. Allergol Int. 2006;55(1):9-16.

Hazin R, Ibrahimi OA, Hazin MI, Kimyai‐Asadi A. Stevens‐Johnson syndrome: Pathogenesis, diagnosis, and Management. Annal Med. 2008;40(2):129-38.

Frantz R, Huang S, Are A, Motaparthi K. Stevens-Johnson Syndrome and toxic epidermal necrolysis: A review of diagnosis and management. Medicina. 2021;57(9):895.

Pejčić AV. Stevens‐Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: A review of published cases. Int J Dermatol. 2020;60(1):12-24.

Toledo-Martinez JF, Galdamez-Carcamo EV, Somoza-Cano FJ, Padilla-Mantilla DA, Alvarenga-Alvarado KL. Recurrent Steven-Johnson/Toxic Epidermal necrolysis overlap syndrome. Cureus. 2022.

Ogiji ED, Maduba CC, Nnadozie UU, Okorie GM, Ukoh UC, Ezeanosike E, et al. Stevens-Johnson Syndrome/toxic epidermal necrolysis overlap following sulfadoxine-pyrimethamine overdose: A case report. PAMJ Clin Med. 2022;8.

K Rajan A, Pal Jeymani.S V, Jose J F, Denagaran DP, Joan Of Arc. M.C M. Ceftriaxone induced Steven Johnson Syndrome: A case report. Int J Pharma Sci Review Res. 2020;65(2):124-7.

Dilley M, Geng B. Immediate and delayed hypersensitivity reactions to antibiotics: Aminoglycosides, clindamycin, linezolid, and Metronidazole. Clin Rev Aller Immunol. 2021;62(3):463-75.

Kodliwadmath A. Phenytoin-induced stevens johnson syndrome with myocarditis: A rare case report. Int Med Case Reports J. 2017;10:229-31.

Thappa D, Jaisankar T, Sanmarkan A, Sori T. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis over a period of 10 years. Indian J Dermatol. 2011;56(1):25.